These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29534329)
1. Late-Stage Functionalization of Drug-Like Molecules Using Diversinates. Kuttruff CA; Haile M; Kraml J; Tautermann CS ChemMedChem; 2018 May; 13(10):983-987. PubMed ID: 29534329 [TBL] [Abstract][Full Text] [Related]
2. An overview of late-stage functionalization in today's drug discovery. Moir M; Danon JJ; Reekie TA; Kassiou M Expert Opin Drug Discov; 2019 Nov; 14(11):1137-1149. PubMed ID: 31411499 [No Abstract] [Full Text] [Related]
3. Reaction of Papaverine with Baran Diversinates Egbewande FA; Coster MJ; Jenkins ID; Davis RA Molecules; 2019 Oct; 24(21):. PubMed ID: 31683610 [TBL] [Abstract][Full Text] [Related]
4. Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compounds. Cannalire R; Pelliccia S; Sancineto L; Novellino E; Tron GC; Giustiniano M Chem Soc Rev; 2021 Jan; 50(2):766-897. PubMed ID: 33350402 [TBL] [Abstract][Full Text] [Related]
5. Development of Highly Chemoselective Oxidative Transformations by Designing Organoradicals. Oisaki K Chem Pharm Bull (Tokyo); 2018; 66(10):907-919. PubMed ID: 30270237 [TBL] [Abstract][Full Text] [Related]
6. An update on late-stage functionalization in today's drug discovery. Montgomery AP; Joyce JM; Danon JJ; Kassiou M Expert Opin Drug Discov; 2023 Jun; 18(6):597-613. PubMed ID: 37114995 [TBL] [Abstract][Full Text] [Related]
8. Non-regioselective functionalization: an underestimate chemical diversity generator in medicinal chemistry. Guariento S; Biagetti M; Ronchi P Future Med Chem; 2021 Apr; 13(7):595-599. PubMed ID: 33657835 [No Abstract] [Full Text] [Related]
9. Organic synthesis provides opportunities to transform drug discovery. Blakemore DC; Castro L; Churcher I; Rees DC; Thomas AW; Wilson DM; Wood A Nat Chem; 2018 Apr; 10(4):383-394. PubMed ID: 29568051 [TBL] [Abstract][Full Text] [Related]
10. Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation. Krueger BA; Dietrich A; Baringhaus KH; Schneider G Comb Chem High Throughput Screen; 2009 May; 12(4):383-96. PubMed ID: 19442066 [TBL] [Abstract][Full Text] [Related]
11. Predictive Minisci late stage functionalization with transfer learning. King-Smith E; Faber FA; Reilly U; Sinitskiy AV; Yang Q; Liu B; Hyek D; Lee AA Nat Commun; 2024 Jan; 15(1):426. PubMed ID: 38225239 [TBL] [Abstract][Full Text] [Related]
12. [Ligand efficiency and lead optimization]. Guo ZR Yao Xue Xue Bao; 2013 Dec; 48(12):1755-62. PubMed ID: 24689231 [TBL] [Abstract][Full Text] [Related]
13. Computational approaches for fragment-based and de novo design. Loving K; Alberts I; Sherman W Curr Top Med Chem; 2010; 10(1):14-32. PubMed ID: 19929832 [TBL] [Abstract][Full Text] [Related]
14. Late stage functionalization of heterocycles using hypervalent iodine(iii) reagents. Budhwan R; Yadav S; Murarka S Org Biomol Chem; 2019 Jul; 17(26):6326-6341. PubMed ID: 31215580 [TBL] [Abstract][Full Text] [Related]
15. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341 [TBL] [Abstract][Full Text] [Related]